Primary HIV infection;HIV-primoinfektion

Therapeutische Umschau

Volumn 61, Issue 10, 2004, Pages 609-612

  Battegay, Manuel ^a   Hirschel, B ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

CLINICAL FEATURE; FEVER; HEADACHE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHADENOPATHY; MONONUCLEOSIS; MYALGIA; RASH; REVIEW; SEROCONVERSION; VIREMIA; VIRUS LOAD; VIRUS TRANSMISSION;

ACUTE DISEASE; ANTI-RETROVIRAL AGENTS; HIV INFECTIONS; HUMANS; VIRAL LOAD;

EID: 7044264460     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.61.10.609     Document Type: Review

References (16)

1. Pilcher CD, Eron JJ, Jr., Vemazza PL, et al. Sexual transmission during the incubation period of primary HIV infection. Jama 2001; 286: 1713-4.
2. Yerly S, Vora S, Rizzardi P, et al. Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. Aids 2001; 15: 2287-92.
3. BAG. Fachkommission Labor und Diagnostik: Diagnostische Empfehlung. HIV-Testkonzept 2004: Neue Richtlinien zum Screening. BAG Bulletin 2004; 10: 168-70.
4. Tindall B, Barker S, Donovan B, et al. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med 1988; 148: 945-9.
5. Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996; 125: 257-64.
6. Vanhems P, Voirin N, Hirschel B, et al. Brief report: incubation and duration of specific symptoms at acute retroviral syndrome as independent predictors of progression to AIDS. J Acquir Immune Defic Syndr 2003; 32:542-4.
7. Vanhems P, Allard R, Cooper DA, et al. Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis 1997; 24: 965-70.
8. Pedersen C, Lindhardt BO, Jensen BL, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. Bmj 1989; 299: 154-7.
9. Dorrucci M, Rezza G, Vlahov D, et al. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study. Aids 1995; 9: 597-604.
10. Yerly S, Kaiser L, Race E, Bru JP, Clavel F, Perrin L. Transmission of antiretroviral-drug-resistant HIV-1 variants. Lancet 1999; 354: 729-33.
11. Gaines H, von Sydow M, Pehrson PO, Lundbegh P. Clinical picture of primary HIV infection presenting as a glandular-fever-like illness. Bmj 1988; 297: 1363-8.
12. Valle SL. Febrile pharyngitis as the primary sign of HIV infection in a cluster of cases linked by sexual contact. Scand J Infect Dis 1987; 19: 13-7.
13. Lapins J, Gaines H, Lindback S, Lidbrink P, Emtestam L. Skin and mucosal characteristics of symptomatic primary HIV-1 infection. AIDS Patient Care STDS 1997; 11: 67-70.
14. Rosenberg ES, Altfeld M, Poon SH, et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000; 407:523-6.
15. Colven R, Harrington RD, Spach DH, Cohen CJ, Hooton TM. Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection. Ann Intern Med 2000; 133:430-4.
16. Kilby JM, Goepfert PA, Miller AP, et al. Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report. Ann Intern Med 2000; 133:435-8.